Should you add Anterix ATEX to your watchlist today 248 20260508 The biggest catalyst for Logistic LPA nobody is watching Smart Money Flows 20260506 What Grupo OMAB segment performance reveals Grupo posts 121 EPS miss vs Street estimates PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower ChinaRussia Partnership Power Imbalance and Mutual Dependence Shape Global Trade Dynamics Open Society Foundations Commits 300 Million to Strengthen US Economic Security and Civil Liberties The HighRise Standoff Inside the East London Tower Block Where 164 Homes Sit Boarded Up Selling a 1 Million Home Will Agent Commissions Be Less Than 6 After the NAR Ruling SpaceX IPO Speculation Jim Cramer Weighs In on Potential Investment AIRelated Layoffs May Not Boost Stocks as Expected Data Suggests Mirabito Expands Footprint with Acquisition of 9 Quicklees Convenience Stores WWEs Saturday Nights Main Event 2026 Preview Potential Content Catalyst for TKO Group Holdings Regulatory Crackdown Intensifies States Challenge Prediction Market Platforms Gokaldas Exports Reports 9 Sequential Revenue Growth in Q4 Amid Global Trade Challenges BYRN Q1 2026 Earnings EPS Misses Estimates but Stock Climbs 317 RPM Q1 2026 Earnings Strong EPS Beat Driven by Margin Expansion and Operational Efficiency Atlanta Braves Holdings Inc Series C BATRK Q1 2026 Earnings EPS Beat Estimates Despite Negative Quarter WAB Q1 2026 Earnings EPS Surpasses Estimates by Nearly 7 Primoris Services PRIM Q1 2026 Earnings EPS Misses Estimates Yet Stock Rallies MMYT Q1 2026 Earnings EPS Miss Sends Shares Lower as Travel Demand Moderates Afya Limited AFYA Faces Downward Pressure as Shares Decline 284 Nexa Resources NEXA Surges 286 as Zinc Market Sentiment Improves CF Industries CF Shares Edge Lower Amid Consolidation MarketAxess MKTX Navigates Narrow Trading Range Amid Quiet Session Processa Pharmaceuticals PCSA Surges 575 as Shares Test Key Resistance Level Microsofts Largest India Data Center on Track for Mid2026 Opening ITRI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Margin Expansion Phathom Pharmaceuticals PHAT Slips 216 as Stock Tests Key Support Levels